SCHEMBL8616347

SCHEMBL8616347

CCS(=O)(=O)Nc1ccc2nc(-c3ccccc3)cc(C(=O)NC(=N)N)c2c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.53
HPGD P15428 3/20 0.53
THRB P10828 2/20 0.53
LMNA P02545 2/20 0.49
HSP90AA1 P07900 1/20 0.49
NPSR1 Q6W5P4 1/20 0.49
MET P08581 1/20 0.49
CA9 Q16790 7/20 0.48
CA12 O43570 4/20 0.48
CA1 P00915 4/20 0.48
CA2 P00918 4/20 0.48
KDM4E B2RXH2 4/20 0.48
CNR1 P21554 2/20 0.48
MAPT P10636 2/20 0.48
MEN1 O00255 5/20 0.47
KMT2A Q03164 5/20 0.47
HTT P42858 2/20 0.47
GPR55 Q9Y2T6 1/20 0.47
CYP3A4 P08684 2/20 0.46
KCNH2 Q12809 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8613501 0.91 CA9 (0.45) ALDH1A1HPGDTHRBLMNACA9
SCHEMBL8613821 0.91 CA9 (0.46) ALDH1A1HPGDTHRBLMNAMET
SCHEMBL8613739 0.90 ALDH1A1 (0.51) ALDH1A1HPGDTHRBLMNAHSP90AA1
SCHEMBL8613823 0.87 CA9 (0.48) ALDH1A1HPGDLMNACA9CA12
SCHEMBL8613241 0.87 KDM4E (0.47) ALDH1A1HPGDLMNACA9CA12
SCHEMBL8619421 0.84 ADORA1 (0.51) ALDH1A1HPGDCA9CA12CA1
SCHEMBL8618218 0.84 CA12 (0.46) ALDH1A1HPGDLMNACA9CA12
SCHEMBL8617762 0.83 KMT2A (0.64) ALDH1A1HPGDNPSR1CA9CA12
SCHEMBL8615144 0.83 CA9 (0.51) ALDH1A1HPGDLMNAHSP90AA1NPSR1
SCHEMBL8616636 0.82 KDM4E (0.52) ALDH1A1HPGDLMNACA9CA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0726254-B1 Quinoline-4-carbonylguanidine derivates, process for producing the same and pharmaceutical preparations containing the compounds MITSUI TOATSU CHEMICALS (JP) 1998-05-06 EP disclosed
US-5627193-A MEDICAL DIAGNOSIS, CARDIOVASCULAR DIAORDERS AND PROTECTION OF ORGANS FOR TRANSPLANTATION MITSUI TOATSU CHEMICALS, INC. (JP) 1997-05-06 US disclosed
EP-0726254-A1 Quinoline-4-carbonylguanidine derivates, process for producing the same and pharmaceutical preparations containing the compounds MITSUI TOATSU CHEMICALS, Inc. (JP) 1996-08-14 EP disclosed